NL-OMON54718
Recruiting
Not Applicable
Heart Failure and Related Risk Factors after Preeclampsia - Heart Failure after Preeclampsia
Medisch Universitair Ziekenhuis Maastricht0 sites2,580 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Heart failure and Preeclampsia
- Sponsor
- Medisch Universitair Ziekenhuis Maastricht
- Enrollment
- 2580
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Women aged \>\= 18 years
- •\* till 30 years after the complicated pregnancy
- •Experienced PE in any pregnancy. PE defined as hypertension (systolic BP \>\=
- •140 mmHg and/or diastolic BP \>\= 90 mmHg) developed after 20 weeks of pregnancy
- •with the development of proteinuria (\>\= 300 mg/ 24 hours).
- •Women who had their last delivery at least 6 months ago., Controls:
- •Women aged \>\= 18 years
- •\* till 30 years after the pregnancy that matches the sequence number of
- •pregnancy of the
- •specifically matched case.
Exclusion Criteria
- •Cases: • Women with auto\-immune diseases prior to the complicated pregnancy. •
- •Chronic hypertension prior to the complicated pregnancy. • Renal disease prior
- •to the complicated pregnancy. • Pregnant women • Women who do not want to be
- •informed about the results of the tests, or women who do not want their general
- •practitioner and specialist(s) to be informed about the test results., Control
- •group: • Women with auto\-immune diseases • Chronic hypertension prior to the
- •matched pregnancy. • Pregnant women • Women who do not want to be informed
- •about the results of the tests, or women who do not want their general
- •practitioner and specialist(s) to be informed about the test results. • Women
- •with IUGR in the matching pregnancy (p\<10\) • Preterm delivery (gestational
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Predictors of outcome in heart failure with preserved ejection fractioI50.19I27.28DRKS00004573Medizinische Universität Wien, Allgemeines Krankenhaus der Stadt Wien, Universitätsklinik II für Innere Medizin , Abteilung für Kardiologie350
Not yet recruiting
Not Applicable
Cardiomyopathy and heart failure risk after treatment for Hodgkin lymphoma or aggressive B cell non-Hodgkin lymphomacardiomyopathyHeartfailure1002532310019280NL-OMON50135ederlands Kanker Instituut800
Recruiting
Not Applicable
TAsmanian Study of Echocardiographic detection of Left ventricular dysfunction (TAS-ELF)Heart failureCardiovascular - Other cardiovascular diseasesACTRN12614000080628Menzies Research Institute Tasmania800
Not yet recruiting
Not Applicable
The effect of a short term, supervised exercise training intervention on longitudinal left ventricular function in patient with heart failure with preserved ejection fractioHeart failure with preserved ejection fractionCardiovascular - Other cardiovascular diseasesACTRN12614001042639Sidhi Laksono Purwowiyoto25
Recruiting
Not Applicable
Survey on the occurrence of heart failure after administration of TARLIGE -MID-NET Cohort Studyeuropathic painJPRN-jRCT2031220177Matsuoka for Yomei24,000